INTEGRATED BIOPHARMA INC·4

Jun 25, 12:07 PM ET

DeSantis Damon 4

4 · INTEGRATED BIOPHARMA INC · Filed Jun 25, 2026

Research Summary

AI-generated summary of this filing

Updated

Integrated Biopharma (INBP) 10% Owner DeSantis Receives Award

What Happened

  • DeSantis Damon (reported as a 10% owner) received a grant of 50,000 derivative securities (reported as an award/acquisition) on 2026-06-24. The Form 4 shows a $0.00 acquisition price, indicating no cash was paid at grant; the filing does not disclose an exercise price or immediate cash value.

Key Details

  • Transaction date: 2026-06-24; filing date: 2026-06-25 (filed timely).
  • Transaction type/code: A (award/grant) — derivative securities (stock options).
  • Amount: 50,000 options granted; price reported = $0.00 (grant price, not exercise price).
  • Vesting/exercisability (footnote): 4 equal installments of 12,500 options vest and become exercisable on 9/30/2026, 12/31/2026, 3/31/2027 and 6/30/2027.
  • Shares owned after transaction: not specified in the supplied filing excerpt.
  • No 10b5-1 plan, tax-withholding, or late-filing flags noted in this filing.

Context

  • This is a grant of options (a derivative award), not an open-market purchase — the recipient gains the right to acquire shares later if and when they exercise the options. Such grants are commonly part of compensation or incentive programs and do not by themselves indicate immediate buying or selling pressure. As a reported 10% owner, DeSantis is a significant holder; the grant increases potential future ownership as options vest and are exercised.

Insider Transaction Report

Form 4
Period: 2026-06-24
DeSantis Damon
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    [F1]
    2026-06-24+50,00050,000 total
    Exercise: $0.20Exp: 2036-06-24Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027.
Signature
/S/ Damon DeSantis|2026-06-25

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT